[HTML][HTML] Antithrombotic and antiplatelet therapy in TAVI patients: a fallow field
JP Collet, G Montalescot - EuroIntervention, 2013 - eurointervention.pcronline.com
Guidelines on antithrombotic therapy after TAVI are scarce and no randomised evaluation
has been performed to demonstrate what the best strategy is. Extrapolation from what we …
has been performed to demonstrate what the best strategy is. Extrapolation from what we …
Real-time survival prediction in emergency situations with unbalanced cardiac patient data
Cardiac disease is a major cause of morbidity and mortality worldwide. Currently, most
researchers focus on identifying risk factors and treatment of cardiac disease. There has …
researchers focus on identifying risk factors and treatment of cardiac disease. There has …
[PDF][PDF] Statins and stent thrombosis
V Braunersreuther, F Mach, F Montecucco - Swiss medical weekly, 2012 - smw.ch
Thrombosis is a rare but serious complication of stent implantation in atherosclerotic
arteries, affecting both bare-metal and drug-eluting stents. Diagnostic criteria for stent …
arteries, affecting both bare-metal and drug-eluting stents. Diagnostic criteria for stent …
Sirolimus-eluting coronary stents in octogenarians: a 1-year analysis of the worldwide e-SELECT Registry
YJ Hong, MH Jeong, A Abizaid, A Banning… - JACC: Cardiovascular …, 2011 - jacc.org
Objectives: The aim of this study was to identify the worldwide practice of Cypher Select
(Cordis Corporation, Bridgewater, New Jersey) or Cypher Select Plus sirolimus-eluting stent …
(Cordis Corporation, Bridgewater, New Jersey) or Cypher Select Plus sirolimus-eluting stent …
Platelet-mediated thrombosis and drug-eluting stents
JF Granada, MJ Price, PA French… - Circulation …, 2011 - Am Heart Assoc
Stent thrombosis is an example of device-induced, platelet-mediated arterial thrombosis.
Rates of stent thrombosis can vary from 1% to 10% depending on the patient population …
Rates of stent thrombosis can vary from 1% to 10% depending on the patient population …
Prevalence and predictors of early discontinuation of dual-antiplatelet therapy after drug-eluting stent implantation in Korean population
The administration of antiplatelet drugs for months after a drug-eluting stent implantation is
critical in decreasing the risk of complications, and premature discontinuation of antiplatelet …
critical in decreasing the risk of complications, and premature discontinuation of antiplatelet …